Glucose intolerance in subclinical hyperthyroid patients

Iranian Journal of Endocrinology and Metabolism

Volumn 14, Issue 2, 2012, Pages 4-

  Azizi, F ^c   Moazezi, Z ^a   Hedayati, M ^b   Shirkhani, Z ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shahid Beheshti University of Medical Sciences   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Glucose intolerance; Hyperthyoidism; Subclinical hyperthyroidism

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; LIOTHYRONINE I 131; PROTIRELIN; THYROTROPIN; THYROXINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; SUBCLINICAL HYPERTHYROIDISM;

EID: 84864054670     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fatourechi V. Subclinical hypothyroidism and subcli-nical hyperthyroidism. Expert Review Endocrinol Metab 2010; 5: 359-373.
2. Intenzo C, Jabbour S, Miller J, Ahmed I, Furlong K, Kushen M, et al. Subclinical Hyperthyroidism: Current Concepts and Scintigraphic Imaging. Clin Nucl Med 2011; 36: e107-e113.
3. Ross DS. Subclinical thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text 8th ed. Philadelphia, PA: JB Lippincott Co, 2000: 1016-1020.
4. Papi G, Pearce EN, Braverman LE, Betterle C, Roti E. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only. Am J Med 2005; 118: 349-361.
5. Biondi B, Filetti S, Schlumberger M. Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 2005; 1: 32-40.
6. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 109-142.
7. Cooper DS. Hyperthyroidism. Lancet 2003; 362: 459-468.
8. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med 2001; 345: 512-516.
9. Marqusee E, Haden ST, Utiger RD. Subclinical thyro-toxicosis. Endocrinol Metab Clin North Am 1998; 27: 37-49.
10. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499.
11. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC.The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-534.
12. De Whalley P. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice. Br J Gen Pract 1995; 45: 93-95.
13. Schlote B, Schaaf L, Schmidt R, Pohl T, Vardarli I, Schiebeler H, et al. Mental and physical state in subc-linical hyperthyroidism: investigations in a normal working populations. Biol Psych 1992; 32: 48-56.
14. Raboudi N, Arem R, Jones RH, Chap Z, Pena J, Chu J, et al. Fasting and postabsorptive hepatic glucose and insulin metabolism in hyperthyroidism. Am J Physiol 1989; 256 (1 Pt 1): E159-E166.
15. Weinstein SP, O'Boyle E, Fisher M, Haber RS. Regulation of GLUT2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of the hepatic glucose transport system. Endocrinology 1994: 135: 649-654.
16. Mitrou P, Rapits SA, Dimitriadis G. Insulin action in hyperthyroidism: A focus on muscle and adipose tissue. Endocr Rev 2010; 31: 663-679.
17. Gimenez-Palop O, Gimenez-Perez G, Mauricio D, Be-rlanga E, Potau N, Vilardell C, et al. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol 2005; 153: 73-79.
18. Iglesias P, Alvarez Fidalgo P, Codoceo R, Diez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol 2003; 59: 621-629.
19. Ikeda T, Fujiyama K, Hoshino T, Takeuchi T, Mashiba H, Tominaga M. Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients. Metabolism 1990; 39: 633-637.
20. Jenkins RC, Valcavi R, Zini M, Frasoldati A, Heler SR, Camacho-Hunber C, et al. Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism. Clin Endocrinol 2000; 52: 187-195.
21. Tosi F, Moghetti P, Castello R, Negri C, Bonora E, Muggeo M. Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism. Metabolism 1996; 45: 1029-1033.
22. Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 2004; 93: 491-496.
23. Yavuz DG, Yuksel M, Deyneli O, Ozen Y, Aydin H, Akalin S. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyp-erthyroid and TSH-suppressed nodular goiter patients. Clin Endocrinol (Oxf) 2004; 61: 515-521.
24. Heemstra KA, Smit JWA, Eustatia-Rutten CF, Heijboer AC, Frölich M, Romijn JA, et al. Glucose tolerance and lipid profile in longterm exogenous subclinical hyper-thyroidism and the effects of restoration of euthyr-oidism, a randomised controlled trial. Clin Endocrinol (Oxf) 2006; 65: 737-744.
25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Medicine 1998; 15: 539-553.
26. Jap TS, Ho LT, Won JG. Insulin secretion and sensitivity in hyperthyroidism. Horm Metab Res 1989; 21: 261-266.
27. O'Meara NM, Blackman JD, Sturis J, Polonsky KS. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism. J Clin Endocrinol Metab 1993; 76: 79-84.
28. Maratou E, Hadjidakis DJ, Peppa M, Alevizaki M, Tsegka K, Lambadiari V, et al. Studies of insulin resistance in patients with clinical and subclinical hyp-erthyroidism. Eur J Endocrinol 2010; 163: 625-630.
29. Chen G, Wu J, Lin Y, Huang B, Yao J, Jiang Q, et al. Associations between cardiovascular risk, insulin resistance, β-cell function and thyroid dysfunction: a cross-sectional study in She ethnic minority group of Fujian Province in China. Eur J Endocrinol 2010; 163: 775-782.
30. Romijn JA, Smit JW, Lamberts SW. Intrinsic imperfections of endocrine replacement therapy. Eur J Endocrinol 2003; 149: 91-97.
31. Müller MJ, Acheson KJ, Jequier E, Burger AG. Effect of thyroid hormone on oxidative and nonoxidative glucose metabolism in humans. Am J Physiol 1988; 255 (2 PT 1): E146-E152.
32. Müller MJ, Burger AG, Ferrannini A, Jequier E, Ach-eson KJ. Golucoregulocory Functions of thyroid hormones. Role o pancreatic hormones. Am J Physiol 1989; 256 (1 Pt 1): E101-E110.
33. Yavuz DG, Yazici D, Toprak A, Deyneli O, Aydin H, Yüksel M, et al. Exogenous subclinical hyperthyroidism impairs endothelial function in nodular goiter patients. Thyroid 2008; 18: 395-400.
34. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, et al. Cardiac effects of long-term thyrotropin-suppressive therapy with levothyroxine. J Clin End-ocrinol Metab1993; 77: 334-338.
35. Biondi B, Fazio S, Palmieri EA, Tremalaterra R, An-gellotti G, Bonè F, et al. Effects of chronic subclinical hyperthyroidism on cardiac morphology and function. Cardiologia 1999; 44: 443-449.
36. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003; 52: 1475-1484.
37. Sorkin JD, Muller DC, Fleg JL, Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 2005; 28: 2626-2632.
38. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999; 354: 617-621.
39. Metter EJ, Windham BG, Maggio M, Simonsick EM, Ling SM, Egan JM, et al. Glucose and insulin measurements from the oral glucose tolerance test and mortality prediction. Diabetes care 2008; 31: 1026-1030.
40. Node k, Inoue T,. Postprandial hyprglycemia as an etiological factor in vascular failure Cardiovasc Diabetol 2009; 8: 23.
41. Al-Shoumer KA, Vasanthy BA, Al-Zaid MM. Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr Pract 2006; 12: 121-130.
42. Kabadi UM, Eisenstein AB. Glucose intolerance in hyp-erthyroidism: Role of glucagon. J Clin Endocrinol Metab 1980; 50: 392-396.